There were 770 press releases posted in the last 24 hours and 438,025 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image